The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading overbought. Our forward projection puts the odds of a 10% gain over the next month near 53%. The street (6 analysts) rates it buy, with a mean price target of $40. It reported earnings in this window, a natural checkpoint for the thesis.
Andersen Group Inc.
ANDG · the NYSE · USD · Market cap $736M · 2,271 employees
Andersen Group Inc.
FAIL · Does not pass the screenPrice as of 17 Nov 2026Daily close, not a live quote
Screened 2026-11-17 · the tape above runs as of 07:15 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price63.08 USD at the 17 Nov 2026 close
- Our value readOvervalued vs our fair value, as of 17 Nov 2026
- Our regime readAccumulation, as of 15 Nov 2026
- Ethical screenDoes not pass
- Last reviewed17 Nov 2026 (1 day ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $44.10 to $62.81, base estimate $53.12 (screen dated 2026-11-17).
- Trend Accumulation
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its accumulation label.
Andersen Group Inc. holds its Accumulation at $63.08. Consolidating, no directional conviction, held for 1 days.
| Phase | Accumulation |
| Quantitative state | Consolidating, no directional conviction, held for 1 days |
| Price at the screen | $63.08 |
| Valuation | 121.44 trailing · 23.93 forward price to earnings |
| Values screen | FAIL · score 70.0 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 81.49% | Below 33% | Interest-bearing debt is 81.5% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 1.45% | Below 33% | Cash held in interest-bearing accounts and securities is 1.4% of assets, under the one-third limit. | Pass |
| Receivables | 66.12% | Below 49% | Money owed to the company is 66.1% of assets, above the 49% limit. | Fail |
| Revenue purity | 0.50% | Below 5% | Only 0.5% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
Andersen's business is in a permissible area, but its interest-bearing debt is about 81% of the company, well over the ~33% line, so it does not pass on the financial screens. Its receivables are also high.
Read as at 2026-11-17. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when ANDG's ethical verdict changes
Today ANDG does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Overvalued vs our fair value, as of 17 Nov 2026: it trades above our $53.12 fair value estimate, 23.70% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-17 screen. The gold marker is the market price at the same screen. The price runs 18.8% above the base estimate.
Third-party analyst targets: 7 covering, consensus Buy. The average target sits −11% from the screen price.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & ProjectionsWhere our models see it going: fair-value estimate $53.12, with a range of $44.10 to $62.81, dated to the 2026-11-17 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWhy it gives us pause
At 23.9x forward earnings, the price already runs ahead of the business. It trades 19% above our $53.12 fair value, so you would be buying at a premium, not a discount.
| Forward P/E | 23.9xfairly priced for its growth rate |
| Trailing P/E | 121.4xexpensive: the price assumes strong growth ahead |
| EPS, trailing | 0.45 |
| EPS, forward | 2.28 |
| Revenue growth | +23.7%strong top-line growth |
| Profit margin | 4.7%barely profitable |
| Return on equity | -67.1%not currently earning a positive return on equity |
| FCF yield | 2.26% |
| Debt to equity | 13.17heavy leverage: higher risk if revenue softens |
| Current ratio | 2.19comfortably covers its short-term bills |
| Short interest, float | 0.21% |
| 52-week range | 18.12 - 57.62 |
| Market cap | $736M |
| Employees | 2,271 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeANDG trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading overbought. Our forward projection puts the odds of a 10% gain over the next month near 53%. The street (6 analysts) rates it buy, with a mean price target of $40. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading overbought. Our forward projection puts the odds of a 10% gain over the next month near 53%. The street (6 analysts) rates it buy, with a mean price target of $40. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading overbought. Our forward projection puts the odds of a 10% gain over the next month near 53%. The street (6 analysts) rates it buy, with a mean price target of $40. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading overbought. Our forward projection puts the odds of a 10% gain over the next month near 53%. The street (6 analysts) rates it buy, with a mean price target of $40. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is momentum reading overbought. Our forward projection puts the odds of a 10% gain over the next month near 53%. The street (6 analysts) rates it buy, with a mean price target of $40. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is momentum reading overbought. Our forward projection puts the odds of a 10% gain over the next month near 53%. The street (6 analysts) rates it buy, with a mean price target of $40. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 14.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is momentum reading overbought. Our forward projection puts the odds of a 10% gain over the next month near 53%. The street (6 analysts) rates it buy, with a mean price target of $40. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is momentum reading overbought. Our forward projection puts the odds of a 10% gain over the next month near 53%. The street (6 analysts) rates it buy, with a mean price target of $40.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 4.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 53%. The street (6 analysts) rates it buy, with a mean price target of $40.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- 3 Stocks Riding The Push For AI Safety And Governance Spending Simply Wall St. · 19 Sep 2026
- Andersen Group shares rise 3% after Baird raises price target InvestorsHub · 1 Sep 2026
- Are Finance Stocks Lagging Morgan Stanley (MS) This Year? Zacks · 25 Aug 2026
- Can Andersen Group (ANDG) Justify Its Valuation As Fresh Equity Raises New Questions? Simply Wall St. · 23 Aug 2026
- Andersen Group Inc (ANDG) (Q2 2026) Earnings Call Highlights: Revenue Surges 23. ... GuruFocus.com · 13 Aug 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $36.65 | +0.3% | · | $1,003 | +0.3% |
| 2 months | $28.25 | +30.1% | · | $1,301 | +30.1% |
| 3 months | $24.53 | +49.8% | · | $1,498 | +49.8% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever ANDG does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.